Biblio
MET signaling overcomes EGFR inhibition in normal and colorectal cancer stem cells causing drug resistance. Gastroenterology. 2019.
. Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistance. Biochim Biophys Acta Rev Cancer. 2020:188437.
. CD44 Expression in Intestinal Epithelium and Colorectal Cancer Is Independent of p53 Status. PLoS One. 2013;8(8):e72849.
.